The expression levels of MTTP, lomitapide’s known target, were undetected in our CRC cells, suggesting that the anticancer activity of lomitapide was independent of its known target, MTTP (Supplementary Fig. 2). This evidence concerns the gene MTTP and colorectal carcinoma.